[Antibiotics and chemotherapeutic agents--from research to practice. VII. Some remarks to practitioners on the properties of polymyxins, lincosanides, spectinomycin, synergistines, bacitracin, novobiocin and flavomycin].
D000818:Animals; D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D001414:Bacitracin / Q000494:pharmacology; D001455:Bambermycins / Q000494:pharmacology; D055598:Chemical Phenomena; D002621:Chemistry; D004352:Drug Resistance, Microbial; D006801:Humans; D009675:Novobiocin / Q000494:pharmacology; D011113:Polymyxins / Q000008:administration & dosage / Q000009:adverse effects / Q000378:metabolism / Q000494:pharmacology; D000198:Spectinomycin / Q000494:pharmacology
D000900:Anti-Bacterial Agents; D011113:Polymyxins; D001455:Bambermycins; D001414:Bacitracin; D009675:Novobiocin; D000198:Spectinomycin
Antibiotiques et chimiothérapiques--de la recherche à la pratique. VII. Quelques remarques destinées aux praticiens sur les particularités des polymyxines, des lincosanides, de la spectinomycine, des synergistines, de la bacitracine, de la novobiocine et de la flavomycine.